Adaptive Biotechnologies Corporation
US ˙ NasdaqGS ˙ US00650F1093

Introducere

Această pagină oferă o analiză cuprinzătoare a istoricului cunoscut al tranzacțiilor privilegiate a Kevin T Conroy. Insiders sunt ofițeri, directori sau investitori importanți într-o companie. Este ilegal ca persoanele din interior să facă tranzacții în companiile lor pe baza unor informații specifice, nepublice. Acest lucru nu înseamnă că este ilegal pentru ei să facă tranzacții în propriile companii. Cu toate acestea, ei trebuie să raporteze toate tranzacțiile către SEC printr-un Formular 4. În ciuda acestor restricții, cercetările academice sugerează că persoanele din interior - în general - tind să depășească piața în propriile companii.

Rentabilitatea medie comercială

Rentabilitatea medie a comerțului este randamentul mediu al tuturor achizițiilor de pe piața deschisă efectuate de persoane din interior în ultimii trei ani. Pentru a calcula acest lucru, examinăm fiecare achiziție neplanificată pe piață deschisă făcută de către insider, excluzând toate tranzacțiile care au fost marcate ca parte a unui plan de tranzacționare 10b5-1. Apoi calculăm performanța medie a acelor tranzacții pe 3, 6 și 12 luni, făcând o medie a fiecărei durate pentru a genera o valoare finală a performanței pentru fiecare tranzacție. În cele din urmă, facem o medie a tuturor valorilor de performanță pentru a calcula o valoare de performanță pentru persoana din interior. Această listă include doar persoane din interior care au efectuat cel puțin trei tranzacții în ultimii doi ani.

Dacă profitabilitatea acestei tranzacții este „N/A”, atunci acesta fie nu a făcut nicio achiziție pe piața deschisă în ultimii trei ani, fie tranzacțiile pe care le-au făcut sunt prea recente pentru a calcula o măsură de performanță fiabilă.

Frecvența actualizării: zilnic

Consultați lista celor mai profitabili comercianți din interior.

Companii cu poziții din interior raportate

Înregistrările SEC indică faptul că Kevin T Conroy a raportat participații sau tranzacții în următoarele companii:

Securitate Titlu Ultimele participații raportate
US:ALGN / Align Technology, Inc. Director 3.553
US:ABT / Abbott Laboratories Director 131.451
US:EXAS / Exact Sciences Corporation President and CEO, Director 0
US:ADPT / Adaptive Biotechnologies Corporation Director 22.968
US:EPZM / Epizyme Inc Director 0
US:US83444K1135 / SomaLogic Inc Director 0
Director 0
Cum se interpretează diagramele

Următoarele diagrame arată performanța acțiunilor de valori mobiliare ulterioare fiecărei tranzacții neplanificate pe piață deschisă efectuată de Kevin T Conroy. Comerțurile neplanificate sunt tranzacții care nu au fost efectuate ca parte a unui plan de tranzacționare 10b5-1. Performanța acțiunilor este reprezentată ca variație procentuală cumulată a prețului acțiunilor. De exemplu, dacă o tranzacție privilegiată a fost efectuată la 1 ianuarie 2019, graficul va afișa modificarea procentuală zilnică a titlului până în prezent. Dacă prețul acțiunilor ar merge de la 10 USD la 15 USD în acest timp, modificarea procentuală cumulativă a prețului acțiunilor ar fi de 50%. O modificare a prețului de la 10 USD la 20 USD ar fi 100%, iar o modificare a prețului de la 10 USD la 5 USD ar fi -50%.

În cele din urmă, încercăm să determinăm cât de strâns se corelează tranzacțiile insider-ului cu randamentele în exces (pozitive sau negative) ale prețului acțiunilor, pentru a vedea dacă insider-ul își programează tranzacțiile pentru a profita de informațiile privilegiate. Luați în considerare situația în care un insider făcea asta. În această situație, ne-am aștepta fie la (a) randamente pozitive după achiziții, fie (b) la profituri negative după vânzare. În cazul punctului (a), graficul CUMPĂRĂRI ar arăta o serie de curbe în pantă ascendentă, indicând randamente pozitive după fiecare tranzacție de cumpărare. În cazul (b), graficul VÂNZARE ar arăta o serie de curbe înclinate în jos, indicând randamente negative după fiecare tranzacție de vânzare.

Cu toate acestea, acest lucru în sine nu este suficient pentru a trage concluzii. Dacă, de exemplu, prețul acțiunilor companiei a fost într-o creștere neciclică de-a lungul multor ani, atunci ne-am aștepta ca toate parcelele post-cumpărare să fie în pantă ascendentă. De asemenea, scăderile non-ciclice de-a lungul multor ani ar avea ca rezultat o pantă descendentă post-tranzacționare. Niciunul dintre aceste grafice nu ar sugera activitate de tranzacționare a informațiilor privilegiate.

Cel mai puternic indicator ar fi o situație în care prețul acțiunilor a fost extrem de ciclic, și au existat atât semnale pozitive în graficul CUMPĂRARE, cât și grafice negative pe graficul VÂNZARE. Această situație ar sugera foarte mult un insider care a programat tranzacțiile în avantajul lor financiar.

Achiziții din interior ADPT / Adaptive Biotechnologies Corporation - Analiza profitului pe termen scurt

În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în ADPT / Adaptive Biotechnologies Corporation. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Max
Pret la
Max
Max
Profit ($)
Randament maxim (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

ADPT / Adaptive Biotechnologies Corporation Insider Trades
Vânzări din interior ADPT / Adaptive Biotechnologies Corporation - Analiza pierderilor pe termen scurt

În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în ADPT / Adaptive Biotechnologies Corporation. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Min
Pret la
Min
Pierdere maximă
Evitat ($)
Pierdere maximă
Evitat (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

ADPT / Adaptive Biotechnologies Corporation Insider Trades
Istoricul tranzacțiilor privilegiate

Acest tabel arată lista completă a tranzacțiilor privilegiate efectuate de Kevin T Conroy, astfel cum a fost dezvăluită Comisiei pentru Bursa de Valori Valori (SEC).

Data fișierului Tran Data Formă Ticker Securitate Cod 10b5-1 Acțiuni Acțiuni rămase La sută
Schimbare
Acțiune
Preț
Tran
Valoare
Rămas
Valoare
2026-05-22 2026-05-20 4 ALGN ALIGN TECHNOLOGY INC
Common Stock
M - Exercise 1.745 3.553 96,52
2026-04-28 3 ABT ABBOTT LABORATORIES
Common shares without par value
131.451
2026-04-28 2026-04-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 2.286 133.737 1,74
2026-03-23 2026-03-23 4 EXAS EXACT SCIENCES CORP
Common Stock
D - Sale to Issuer -117.427 0 -100,00
2026-03-23 2026-03-23 4 EXAS EXACT SCIENCES CORP
Common Stock
D - Sale to Issuer -86.750 0 -100,00
2026-03-23 2026-03-23 4 EXAS EXACT SCIENCES CORP
Common Stock
D - Sale to Issuer -46.538 0 -100,00
2026-03-23 2026-03-23 4 EXAS EXACT SCIENCES CORP
Common Stock
D - Sale to Issuer -29.061 0 -100,00
2026-03-23 2026-03-23 4 EXAS EXACT SCIENCES CORP
Common Stock
D - Sale to Issuer -1.397.738 0 -100,00
2026-03-23 2026-03-23 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 119.312 1.397.738 9,33
2026-03-03 2026-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -13.060 1.278.045 -1,01 103,25 -1.348.445 131.958.146
2026-03-03 2026-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 27.786 1.291.105 2,20
2026-03-03 2026-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -10.419 1.263.319 -0,82 103,25 -1.075.762 130.437.687
2026-03-03 2026-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 22.168 1.273.738 1,77
2026-03-03 2026-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -8.528 1.251.570 -0,68 103,25 -880.516 129.224.602
2026-03-03 2026-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 18.143 1.260.098 1,46
2026-02-27 2026-02-25 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -6.196 1.241.955 -0,50 103,45 -640.976 128.480.245
2026-02-27 2026-02-25 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 13.181 1.248.151 1,07
2025-12-30 2025-12-23 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -155.417 1.234.970 -11,18 101,82 -15.824.559 125.744.645
2025-12-30 2025-12-23 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 330.674 155.417 -188,68
2025-12-30 2025-12-23 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -65.014 1.059.713 -5,78 101,82 -6.619.725 107.899.978
2025-12-30 2025-12-23 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 138.326 1.124.727 14,02
2025-12-30 2025-12-23 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -115.118 986.401 -10,45 101,82 -11.721.315 100.435.350
2025-12-30 2025-12-23 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 244.931 1.101.519 28,59
2025-05-22 2025-05-21 4 ALGN ALIGN TECHNOLOGY INC
Common Stock
M - Exercise 1.148 1.808 173,94
2025-04-29 2019-11-27 5/A EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -22.063 0 -100,00
2025-04-29 2019-11-27 5/A EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -43.126 22.063 -66,16
2025-04-29 2019-11-27 5/A EXAS EXACT SCIENCES CORP
Common Stock
G - Gift 43.126 893.818 5,07
2025-04-29 2019-05-06 5/A EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -28.660 850.692 -3,26
2025-04-29 2020-10-26 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -163.000 602.120 -21,30
2025-04-29 2024-05-14 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -74.599 779.944 -8,73
2025-03-10 2025-03-07 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -48.929 1.154.340 -4,07 47,06 -2.302.599 54.323.240
2025-03-10 2025-03-07 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 66.723 1.203.269 5,87 22,38 1.493.261 26.929.160
2025-03-04 2025-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -10.419 1.136.546 -0,91 47,82 -498.237 54.349.630
2025-03-04 2025-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 22.167 1.146.965 1,97
2025-03-04 2025-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -8.528 1.124.798 -0,75 47,82 -407.809 53.787.840
2025-03-04 2025-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 18.143 1.133.326 1,63
2025-02-26 2025-02-25 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -6.195 1.115.183 -0,55 51,28 -317.680 57.186.584
2025-02-26 2025-02-25 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 13.180 1.121.378 1,19
2025-02-21 2025-02-20 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -21.140 1.108.198 -1,87 50,48 -1.067.147 55.941.835
2025-02-21 2025-02-20 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 48.044 1.129.338 4,44
2025-02-21 2025-02-19 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -3.271 1.081.294 -0,30 49,63 -162.340 53.664.621
2025-02-21 2025-02-19 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 10.374 1.084.565 0,97
2024-11-13 2024-11-13 4 EXAS EXACT SCIENCES CORP
Common Stock
P - Purchase 19.500 1.074.191 1,85 51,35 1.001.325 55.159.708
2024-05-24 2024-05-22 4 ALGN ALIGN TECHNOLOGY INC
Common Stock
M - Exercise 660 660
2024-05-02 2024-05-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -1.155 1.156.191 -0,10 60,15 -69.473 69.544.889
2024-05-02 2024-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 708 1.157.346 0,06 30,02 21.254 34.743.527
2024-05-02 2024-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 2.489 1.156.638 0,22
2024-03-04 2024-03-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -8.271 1.299.496 -0,63 59,32 -490.636 77.086.103
2024-03-04 2024-02-29 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 18.143 1.307.767 1,41
2024-02-28 2024-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -6.263 1.289.624 -0,48 56,89 -356.302 73.366.709
2024-02-28 2024-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 13.181 1.295.887 1,03
2024-02-26 2024-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -61.560 1.282.706 -4,58 57,53 -3.541.547 73.794.076
2024-02-26 2024-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 102.837 1.344.266 8,28 13,96 1.435.605 18.765.953
2024-02-23 2024-02-22 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -11.565 1.241.429 -0,92 59,78 -691.356 74.212.626
2024-02-23 2024-02-21 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 23.238 1.252.994 1,89
2024-02-22 2024-02-21 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -4.975 1.229.756 -0,40 61,50 -305.962 75.629.994
2024-02-22 2024-02-20 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 10.374 1.234.731 0,85
2024-02-16 2024-02-15 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -14.791 1.224.357 -1,19 61,43 -908.611 75.212.251
2024-02-16 2024-02-14 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 31.133 1.239.148 2,58
2024-02-16 2023-05-01 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 709 1.208.015 0,06 30,02 21.284 36.264.610
2023-03-08 2023-03-06 4 ADPT Adaptive Biotechnologies Corp
Common Stock
A - Award 14.775 22.968 180,34
2023-03-01 2023-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -10.416 1.207.306 -0,86 61,12 -636.626 73.790.543
2023-03-01 2023-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 9.312 1.217.722 0,77
2023-03-01 2023-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 13.180 1.208.410 1,10
2023-02-23 2023-02-22 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -4.764 1.195.230 -0,40 62,72 -298.798 74.964.826
2023-02-23 2023-02-21 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 10.374 1.199.994 0,87
2023-02-16 2023-02-15 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale -14.617 1.189.620 -1,21 65,59 -958.729 78.027.176
2023-02-16 2023-02-14 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 31.132 1.204.237 2,65
2023-02-14 2023-02-13 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -4.527 1.173.105 -0,38 64,55 -292.218 75.723.928
2023-02-14 2023-02-10 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 9.705 1.177.632 0,83
2022-08-16 2022-08-12 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
D - Sale to Issuer -8.994 0 -100,00
2022-08-16 2022-08-12 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
D - Sale to Issuer -53.324 8.994 -85,57
2022-07-06 2022-07-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -7 1.167.927 0,00 40,75 -285 47.593.025
2022-07-06 2022-05-02 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 328 1.167.934 0,03 47,41 15.550 55.371.751
2022-07-05 2022-06-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 10.204 62.318 19,58 1,47 15.000 91.607
2022-05-19 2022-05-17 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 41.006 41.006
2022-05-19 2022-05-17 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 8.994 52.114 20,86
2022-04-01 2022-03-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 13.043 43.120 43,37 1,15 14.999 49.588
2022-03-18 2022-03-17 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -2.253 66.047 -3,30
2022-03-18 2022-03-17 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -4.612 235.388 -1,92
2022-03-18 2022-03-17 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -229.757 0 -100,00
2022-03-18 2022-03-17 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 2.253 1.167.606 0,19 44,37 99.966 51.806.678
2022-03-18 2022-03-17 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 4.612 1.165.353 0,40 21,68 99.988 25.264.853
2022-03-18 2022-03-17 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 229.757 1.160.741 24,68 5,70 1.309.615 6.616.224
2022-03-02 2022-03-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -14.299 930.984 -1,51 76,69 -1.096.590 71.397.163
2022-03-02 2022-02-28 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -9.312 9.312 -50,00
2022-03-02 2022-02-28 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -20.575 0 -100,00
2022-03-02 2022-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 9.312 945.283 0,99
2022-03-02 2022-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20.575 935.971 2,25
2022-03-01 2022-02-25 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 52.722 52.722
2022-02-25 2022-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -27.126 915.396 -2,88 70,10 -1.901.533 64.169.260
2022-02-25 2022-02-23 4 EXAS EXACT SCIENCES CORP
Performance Stock Units
M - Exercise -58.643 0 -100,00
2022-02-25 2022-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 58.643 942.522 6,63
2022-02-24 2022-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -5.188 883.879 -0,58 69,05 -358.231 61.031.845
2022-02-24 2022-02-22 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -10.373 31.122 -25,00
2022-02-24 2022-02-22 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 10.373 889.067 1,18
2022-02-16 2022-02-15 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -14.409 878.694 -1,61 79,55 -1.146.236 69.900.108
2022-02-16 2022-02-14 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -31.133 62.265 -33,33
2022-02-16 2022-02-14 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -96.758 0 -100,00
2022-02-16 2022-02-14 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -94.425 0 -100,00
2022-02-16 2022-02-14 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 31.133 893.103 3,61 78,33 2.438.648 69.956.758
2022-02-16 2022-02-14 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 96.758 861.970 12,64 10,82 1.046.922 9.326.515
2022-02-16 2022-02-14 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 94.425 765.212 14,08 9,07 856.435 6.940.473
2022-01-28 2022-01-26 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
A - Award 16.722 16.722
2022-01-28 2022-01-26 4 ADPT Adaptive Biotechnologies Corp
Common Stock
A - Award 6.689 8.193 444,75
2022-01-19 2022-01-14 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 6.407 670.787 0,96
2022-01-04 2021-12-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 6.000 30.077 24,92 2,50 15.000 75.192
2021-11-03 2021-11-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -16.922 664.380 -2,48 93,88 -1.588.637 62.371.994
2021-10-05 2021-10-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -17.078 681.302 -2,45 93,64 -1.599.184 63.797.119
2021-10-01 2021-09-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 2.930 24.077 13,86 5,12 15.002 123.274
2021-09-03 2021-09-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -18.978 698.380 -2,65 104,42 -1.981.683 72.924.840
2021-09-03 2021-09-01 4 SLGCW SomaLogic, Inc.
Class B Common Stock
M - Exercise -25.000 0 -100,00
2021-09-03 2021-09-01 4 SLGCW SomaLogic, Inc.
Warrants to purchase Class A Common Stock (right to buy)
A - Award 166.666 166.666
2021-09-03 2021-09-01 4 SLGCW SomaLogic, Inc.
Class A Common Stock
J - Other 25.000 25.000
2021-08-04 2021-08-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -19.970 717.358 -2,71 107,50 -2.146.775 77.115.985
2021-07-06 2021-07-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -7.784 737.328 -1,04 123,43 -960.779 91.008.395
2021-07-01 2021-06-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 1.805 21.147 9,33 8,31 15.000 175.732
2021-06-15 2021-06-11 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 40.559 40.559
2021-06-15 2021-06-11 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 8.060 19.342 71,44
2021-06-03 2021-06-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -12.384 745.112 -1,63 111,00 -1.374.624 82.707.432
2021-05-05 2021-05-03 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -19.240 757.496 -2,48 131,09 -2.522.172 99.300.151
2021-05-05 2021-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 328 776.736 0,04 64,74 21.235 50.285.889
2021-04-05 2021-04-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -22.755 776.408 -2,85 132,30 -3.010.486 102.718.778
2021-04-01 2021-03-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 1.723 11.282 18,02 8,71 15.007 98.266
2021-03-03 2021-03-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -9.796 799.163 -1,21 138,42 -1.355.962 110.620.142
2021-03-03 2021-03-01 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -20.575 20.575 -50,00
2021-03-03 2021-03-01 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20.575 808.959 2,61
2021-03-02 2021-03-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -26.958 788.384 -3,31 136,79 -3.687.585 107.843.047
2021-03-02 2021-03-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -4.335 815.342 -0,53 137,44 -595.802 112.060.604
2021-03-02 2021-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -9.312 18.624 -33,33
2021-03-02 2021-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 9.312 819.677 1,15
2021-02-25 2021-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -16.420 810.365 -1,99 136,30 -2.238.046 110.452.750
2021-02-25 2021-02-23 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -34.325 0 -100,00
2021-02-25 2021-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 34.325 826.785 4,33
2021-02-23 2021-02-19 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 41.495 41.495
2021-02-18 2021-02-17 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -15.825 792.460 -1,96 142,66 -2.257.594 113.052.344
2021-02-18 2021-02-16 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -31.132 93.398 -25,00
2021-02-18 2021-02-16 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 31.132 808.285 4,01
2021-02-17 2021-02-14 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
A - Award 3.759 3.759
2021-02-17 2021-02-14 4 ADPT Adaptive Biotechnologies Corp
Common Stock
A - Award 1.504 1.504
2021-02-09 2021-02-05 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -17.543 229.757 -7,09
2021-02-09 2021-02-05 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 17.543 777.153 2,31 5,70 99.995 4.429.772
2021-02-03 2021-02-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -30.344 759.610 -3,84 138,07 -4.189.596 104.879.353
2021-02-03 2020-12-28 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -35.750 789.954 -4,33
2021-01-07 2021-01-04 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -31.814 825.704 -3,71 128,74 -4.095.734 106.301.133
2021-01-05 2020-12-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 1.024 9.559 12,00 10,86 11.121 103.811
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -100 857.518 -0,01 126,59 -12.659 108.553.204
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -100 857.618 -0,01 126,49 -12.649 108.480.101
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -7.043 857.718 -0,81 125,92 -886.855 108.003.851
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -10.840 864.761 -1,24 124,88 -1.353.699 107.991.354
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -7.776 875.601 -0,88 124,03 -964.457 108.600.792
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -2.918 883.377 -0,33 122,91 -358.651 108.575.867
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -1.800 886.295 -0,20 122,05 -219.690 108.172.305
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -400 888.095 -0,05 124,71 -49.884 110.754.327
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -600 888.495 -0,07 123,45 -74.070 109.684.708
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -9.577 889.095 -1,07 122,33 -1.171.554 108.762.991
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -10.229 898.672 -1,13 121,52 -1.243.028 109.206.621
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -6.512 908.901 -0,71 120,45 -784.370 109.477.125
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -1.108 915.413 -0,12 119,18 -132.051 109.098.921
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -4.393 916.521 -0,48 118,32 -519.780 108.442.765
2020-10-02 2020-10-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -1.136 920.914 -0,12 105,20 -119.507 96.880.153
2020-10-02 2020-10-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -5.200 922.050 -0,56 104,70 -544.440 96.538.635
2020-10-02 2020-10-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -9.391 927.250 -1,00 103,57 -972.626 96.035.282
2020-10-02 2020-10-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -11.698 936.641 -1,23 102,86 -1.203.256 96.342.893
2020-10-01 2020-09-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 933 8.535 12,27 11,93 11.131 101.823
2020-09-02 2020-09-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -19.927 948.339 -2,06 75,03 -1.495.123 71.153.875
2020-08-04 2020-08-03 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -198 968.266 -0,02 95,00 -18.810 91.985.270
2020-08-04 2020-08-03 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -25.000 968.464 -2,52 93,79 -2.344.750 90.832.239
2020-08-04 2020-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 501 993.464 0,05 42,44 21.262 42.162.612
2020-07-06 2020-07-01 4 ARYA ARYA SCIENCES ACQUISITION CORP.
Class B Ordinary Shares
D - Sale to Issuer -30.000 0 -100,00
2020-07-01 2020-06-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 693 7.602 10,03 16,06 11.130 122.088
2020-06-02 2020-05-29 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 14.013 14.013
2020-04-02 2020-03-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 717 6.909 11,58 15,51 11.121 107.159
2020-03-02 2020-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -9.750 992.963 -0,97 80,17 -781.658 79.605.844
2020-03-02 2020-02-27 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -20.575 41.150 -33,33
2020-03-02 2020-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20.575 1.002.713 2,09
2020-02-28 2020-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -13.875 982.138 -1,39 80,27 -1.113.746 78.836.217
2020-02-28 2020-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -9.312 27.936 -25,00
2020-02-28 2020-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -20.025 0 -100,00
2020-02-28 2020-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 9.312 996.013 0,94
2020-02-28 2020-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20.025 986.701 2,07
2020-02-26 2020-02-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -18.115 966.676 -1,84 85,11 -1.541.768 82.273.794
2020-02-26 2020-02-24 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -34.325 34.325 -50,00
2020-02-26 2020-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 34.325 984.791 3,61
2020-02-18 2020-02-13 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
A - Award 8.888 8.888
2020-02-18 2020-02-14 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 124.530 124.530
2020-02-18 2020-02-14 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 100.916 100.916
2020-02-14 2019-11-27 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift 21.729 21.729
2020-02-14 2019-11-27 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift 21.730 21.730
2020-02-14 2019-11-27 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift 21.730 21.730
2020-02-14 2019-11-27 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -65.189 0 -100,00
2020-01-03 2019-12-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 452 6.192 7,87 24,60 11.119 152.323
2019-12-18 2019-12-16 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -4.277 66.723 -6,02
2019-12-18 2019-12-16 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -7.163 102.837 -6,51
2019-12-18 2019-12-16 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 4.277 950.466 0,45 23,38 99.996 22.221.895
2019-12-18 2019-12-16 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 7.163 946.189 0,76 13,96 99.995 13.208.798
2019-12-18 2019-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 500 939.026 0,05 42,44 21.220 39.852.263
2019-10-02 2019-09-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 1.078 5.740 23,12 10,32 11.125 59.237
2019-07-02 2019-06-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 887 4.662 23,50 12,55 11.132 58.508
2019-06-07 2019-05-31 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 17.633 17.633
2019-06-07 2019-03-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 897 3.775 31,17 12,39 11.114 46.772
2019-03-12 2019-03-11 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -11.227 938.526 -1,18 87,21 -979.129 81.850.730
2019-03-12 2019-03-09 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -24.400 0 -100,00
2019-03-12 2019-03-09 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 24.400 949.753 2,64
2019-03-01 2019-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -10.014 925.353 -1,07 93,20 -933.345 86.246.601
2019-02-28 2019-02-27 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -20.575 61.725 -25,00
2019-02-28 2019-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20.575 935.367 2,25
2019-02-28 2019-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -9.169 914.792 -0,99 95,07 -871.734 86.972.935
2019-02-28 2019-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 37.248 37.248
2019-02-28 2019-02-26 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 34.110 34.110
2019-02-28 2019-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -20.025 20.025 -50,00
2019-02-28 2019-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20.025 923.961 2,22
2019-02-26 2019-02-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -16.400 903.936 -1,78 90,55 -1.485.036 81.852.309
2019-02-26 2019-02-23 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -34.325 68.650 -33,33
2019-02-26 2019-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 34.325 920.336 3,87
2019-01-25 2019-01-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -23.236 886.011 -2,56 82,49 -1.916.668 73.084.389
2019-01-25 2019-01-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -181.250 909.247 -16,62 81,90 -14.844.194 74.466.420
2019-01-25 2019-01-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -36.453 1.090.497 -3,23 80,78 -2.944.783 88.093.619
2019-01-25 2019-01-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -28.605 1.126.950 -2,48 79,89 -2.285.339 90.035.416
2019-01-25 2019-01-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -34.853 1.155.555 -2,93 78,80 -2.746.416 91.057.734
2019-01-25 2019-01-24 4 EXAS EXACT SCIENCES CORP
Performance Share Units
M - Exercise -304.397 0 -100,00
2019-01-25 2019-01-24 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 304.397 1.190.408 34,36
2019-01-04 2019-01-02 4 EXAS EXACT SCIENCES CORP
Performance Share Units
A - Award 304.397 304.397
2018-11-14 2018-11-12 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -163.514 0 -100,00
2018-11-14 2018-11-12 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -163.514 886.011 -15,58 69,00 -11.282.466 61.134.759
2018-11-14 2018-11-12 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 163.514 1.049.525 18,46 0,83 135.717 871.106
2018-11-14 2018-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 3.572 886.011 0,40 5,95 21.253 5.271.765
2018-07-02 2018-07-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 2.878 2.878 13,55 38.997 38.997
2018-05-31 2018-05-18 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 12.500 12.500
2018-03-13 2018-03-12 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -11.459 882.439 -1,28 52,19 -598.091 46.058.021
2018-03-13 2018-03-09 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -24.400 24.400 -50,00
2018-03-13 2018-03-09 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 24.400 893.898 2,81
2018-02-28 2018-02-27 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 82.300 82.300
2018-02-28 2018-02-27 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 68.300 68.300
2018-02-28 2018-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -9.085 869.498 -1,03 44,10 -400.630 38.343.123
2018-02-28 2018-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -20.025 40.050 -33,33
2018-02-28 2018-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20.025 878.583 2,33
2018-02-27 2018-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -25.319 858.558 -2,86 42,34 -1.071.956 36.349.629
2018-02-27 2018-02-24 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -19.500 0 -100,00
2018-02-27 2018-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19.500 883.877 2,26
2018-02-27 2018-02-23 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -34.325 102.975 -25,00
2018-02-27 2018-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 34.325 864.377 4,14
2018-02-13 2018-02-09 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -101.488 163.514 -38,30
2018-02-13 2018-02-09 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale -9.458 830.052 -1,13 46,29 -437.839 38.425.597
2018-02-13 2018-02-09 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale -50.504 839.510 -5,67 46,54 -2.350.456 39.070.795
2018-02-13 2018-02-09 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale -41.526 890.014 -4,46 44,60 -1.851.977 39.692.844
2018-02-13 2018-02-09 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise X 101.488 931.540 12,23 0,83 84.235 773.178
2018-01-25 2018-01-23 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -110.439 265.002 -29,42
2018-01-25 2018-01-23 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale -30.036 830.052 -3,49 51,66 -1.551.660 42.880.486
2018-01-25 2018-01-23 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale -41.588 860.088 -4,61 50,72 -2.109.427 43.625.384
2018-01-25 2018-01-23 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale -26.738 901.676 -2,88 49,54 -1.324.707 44.672.636
2018-01-25 2018-01-23 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale -12.077 928.414 -1,28 48,87 -590.167 45.368.807
2018-01-25 2018-01-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise X 110.439 940.491 13,31 0,83 91.664 780.608
2018-01-17 2018-01-12 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -125.402 375.441 -25,04
2018-01-17 2018-01-12 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale -25.912 830.052 -3,03 53,24 -1.379.659 44.195.289
2018-01-17 2018-01-12 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale -99.490 855.964 -10,41 52,68 -5.240.934 45.090.472
2018-01-17 2018-01-12 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise X 125.402 955.454 15,11 0,83 104.084 793.027
2017-12-26 2017-12-22 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -123.512 500.843 -19,78
2017-12-26 2017-12-22 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -27.065 830.052 -3,16 53,36 -1.444.053 44.287.424
2017-12-26 2017-12-22 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -96.447 857.117 -10,11 52,37 -5.050.736 44.885.503
2017-12-26 2017-12-22 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 123.512 953.564 14,88 0,83 102.515 791.458
2017-12-08 2017-12-06 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -121.849 624.355 -16,33
2017-12-08 2017-12-06 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -28.370 830.052 -3,30 53,80 -1.526.448 44.660.948
2017-12-08 2017-12-06 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -93.479 858.422 -9,82 53,35 -4.986.731 45.793.380
2017-12-08 2017-12-06 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 121.849 951.901 14,68 0,83 101.135 790.078
2017-11-22 2017-11-21 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -134.057 746.204 -15,23
2017-11-22 2017-11-21 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -134.057 830.052 -13,90 59,50 -7.976.660 49.389.754
2017-11-22 2017-11-21 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 134.057 964.109 16,15 0,83 111.267 800.210
2017-11-13 2017-11-09 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -137.815 880.261 -13,54
2017-11-13 2017-11-09 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -5.424 830.052 -0,65 60,05 -325.690 49.841.302
2017-11-13 2017-11-09 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -80.405 835.486 -8,78 59,43 -4.778.550 49.653.768
2017-11-13 2017-11-09 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -51.976 915.891 -5,37 58,59 -3.045.430 53.664.801
2017-11-13 2017-11-09 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 137.815 967.867 16,60 0,83 114.386 803.330
2017-08-17 2017-08-17 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -9.242 96.758 -8,72
2017-08-17 2017-08-17 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 9.242 830.052 1,13 10,82 99.998 8.981.163
2017-07-28 2017-07-27 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 137.300 137.300
2017-07-28 2017-07-27 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 240.000 240.000
2017-07-28 2017-05-01 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 3.571 820.810 0,44 5,95 21.247 4.883.820
2017-03-14 2017-03-13 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -12.059 817.239 -1,45 21,16 -255.168 17.292.777
2017-03-13 2017-03-09 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -24.400 48.800 -33,33
2017-03-13 2017-03-09 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 24.400 829.298 3,03
2017-02-28 2017-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -19.557 804.898 -2,37 21,48 -420.084 17.289.209
2017-02-28 2017-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -20.025 60.075 -25,00
2017-02-28 2017-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20.025 824.455 2,49
2017-02-28 2017-02-24 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -19.500 19.500 -50,00
2017-02-28 2017-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19.500 804.430 2,48
2017-02-28 2017-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -7.577 784.930 -0,96 21,57 -163.436 16.930.940
2017-02-24 2017-02-22 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -19.375 0 -100,00
2017-02-24 2017-02-22 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19.375 792.507 2,51
2017-02-07 2017-02-06 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2016-11-15 2016-11-15 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -33.075 94.425 -25,94
2016-11-15 2016-11-15 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 33.075 773.132 4,47 9,07 299.990 7.012.307
2016-11-15 2016-11-15 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale -275.000 740.057 -27,09 17,36 -4.774.000 12.847.390
2016-11-15 2016-11-14 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale -275.000 1.015.057 -21,32 17,52 -4.818.000 17.783.799
2016-11-15 2016-11-11 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -600.000 1.018.076 -37,08
2016-11-15 2016-11-11 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale -50.000 1.290.057 -3,73 17,68 -884.000 22.808.208
2016-11-15 2016-11-11 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 600.000 1.340.057 81,07 0,83 498.000 1.112.247
2016-07-27 2016-07-25 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -25.000 0 -100,00
2016-07-27 2016-07-25 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 25.000 740.057 3,50
2016-07-27 2016-05-02 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 2.750 715.057 0,39 5,95 16.362 4.254.589
2016-03-11 2016-03-09 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -24.400 73.200 -25,00
2016-03-11 2016-03-09 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 24.400 712.307 3,55
2016-03-11 2016-02-26 4/A EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 80.100 80.100
2016-03-11 2016-02-26 4/A EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 247.300 247.300
2016-03-11 2016-02-26 4/A EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -6.895 637.907 -1,07 5,81 -40.060 3.706.240
2016-03-01 2016-03-01 4 EXAS EXACT SCIENCES CORP
Common Stock
P - Purchase X 50.000 687.907 7,84 5,00 250.000 3.439.535
2016-02-29 2016-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -6.895 637.907 -1,07 5,81 -40.060 3.706.240
2016-02-26 2016-02-24 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -19.500 39.000 -33,33
2016-02-26 2016-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19.500 644.802 3,12
2016-02-24 2016-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -6.866 625.302 -1,09 6,39 -43.874 3.995.680
2016-02-24 2016-02-22 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -19.375 19.375 -50,00
2016-02-24 2016-02-22 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19.375 632.168 3,16
2016-01-13 2016-01-11 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -265.924 1.618.076 -14,11
2016-01-13 2016-01-11 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 265.924 612.973 76,62 0,83 220.717 508.768
2016-01-05 2016-01-04 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -10.750 346.869 -3,01 8,72 -93.740 3.024.698
2016-01-05 2015-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -20.466 0 -100,00
2016-01-05 2015-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20.466 357.619 6,07
2016-01-05 2015-09-21 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -787 337.153 -0,23
2016-01-05 2015-06-30 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -340 337.940 -0,10
2016-01-05 2015-04-21 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -1.000 338.280 -0,29
2016-01-05 2015-02-18 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -395 339.280 -0,12
2015-12-28 2015-12-23 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -81.000 1.884.000 -4,12
2015-12-28 2015-12-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 81.000 338.335 31,48 0,83 67.230 280.818
2015-07-28 2015-07-27 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -11.386 257.335 -4,24 24,04 -273.719 6.186.333
2015-07-28 2015-07-25 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -25.000 25.000 -50,00
2015-07-28 2015-07-25 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 25.000 268.721 10,26
2015-07-28 2015-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 1.195 244.061 0,49 17,78 21.247 4.339.405
2015-03-11 2015-03-09 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 97.600 97.600
2015-03-11 2015-03-09 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 71.000 71.000
2015-02-26 2015-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -8.425 243.866 -3,34 23,44 -197.482 5.716.219
2015-02-26 2015-02-24 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -19.500 58.500 -25,00
2015-02-26 2015-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19.500 252.291 8,38
2015-02-25 2015-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -9.798 232.791 -4,04 22,90 -224.374 5.330.914
2015-02-25 2015-02-23 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -19.375 38.750 -33,33
2015-02-25 2015-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19.375 242.589 8,68
2015-01-05 2015-01-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -9.484 223.214 -4,08 26,72 -253.412 5.964.278
2015-01-05 2014-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -20.467 20.466 -50,00
2015-01-05 2014-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20.467 232.698 9,64
2015-01-05 2014-10-28 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -1.025 212.231 -0,48
2015-01-05 2014-07-07 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -583 213.256 -0,27
2015-01-05 2014-06-09 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift 65.189 65.189
2015-01-05 2014-06-09 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -65.189 213.839 -23,36
2015-01-05 2014-03-14 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -1.535 279.028 -0,55
2014-10-20 2014-10-20 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -135.000 1.965.000 -6,43
2014-10-20 2014-10-20 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise X -133.334 2.100.000 -5,97
2014-10-20 2014-10-20 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 135.000 280.563 92,74 0,83 112.050 232.867
2014-10-20 2014-10-20 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -133.334 145.563 -47,81 23,93 -3.190.989 3.483.657
2014-10-20 2014-10-20 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise X 133.334 278.897 91,60 0,83 110.667 231.485
2014-10-20 2014-10-17 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise X -133.333 2.233.334 -5,63
2014-10-20 2014-10-17 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -133.333 145.563 -47,81 23,68 -3.157.632 3.447.267
2014-10-20 2014-10-17 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise X 133.333 278.896 91,60 0,83 110.666 231.484
2014-10-20 2014-10-16 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise X -133.333 2.366.667 -5,33
2014-10-20 2014-10-16 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -133.333 145.563 -47,81 22,84 -3.045.566 3.324.921
2014-10-20 2014-10-16 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise X 133.333 278.896 91,60 0,83 110.666 231.484
2014-07-29 2014-07-25 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -25.000 50.000 -33,33
2014-07-29 2014-07-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -11.336 145.563 -7,23 15,99 -181.263 2.327.552
2014-07-29 2014-07-25 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 25.000 156.899 18,95
2014-07-29 2014-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 2.721 131.899 2,11 7,81 21.251 1.030.131
2014-06-20 2013-11-12 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -4.092 118.511 -3,34
2014-02-25 2014-02-24 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 78.000 78.000
2014-02-25 2014-02-24 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 110.000 110.000
2014-02-25 2014-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -8.708 134.374 -6,09 14,07 -122.522 1.890.642
2014-02-25 2014-02-22 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19.375 143.082 15,66
2014-01-03 2014-01-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -9.271 123.707 -6,97 11,96 -110.881 1.479.536
2014-01-03 2014-01-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -17.108 112.511 -13,20 11,96 -204.612 1.345.632
2014-01-03 2013-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -20.467 40.933 -33,33
2014-01-03 2013-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 61.400 61.400
2014-01-03 2013-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -37.767 0 -100,00
2014-01-03 2013-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20.467 132.978 18,19
2014-01-03 2013-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 37.767 129.619 41,12
2013-07-29 2013-07-25 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 75.000 75.000
2013-07-29 2013-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 5.082 91.852 5,86 7,81 39.690 717.364
2013-02-25 2013-02-22 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 77.500 77.500
2013-02-25 2013-02-22 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 106.000 106.000
2013-01-03 2012-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -37.767 37.768 -50,00
2013-01-03 2012-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -16.410 86.770 -15,90 10,59 -173.782 918.894
2013-01-03 2012-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 37.767 103.180 57,74
2013-01-03 2012-12-26 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -1.500 65.413 -2,24
2012-11-02 2012-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
P - Purchase 2.000 66.913 3,08 9,13 18.260 610.916
2012-11-02 2012-11-01 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 3.277 64.913 5,32 5,48 17.958 355.723
2012-11-02 2012-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 2.528 61.636 4,28 5,48 13.853 337.765
2012-11-02 2012-03-20 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -995 59.108 -1,66
2012-11-02 2012-03-05 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -2.115 60.103 -3,40
2012-02-29 2012-02-27 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 127.500 127.500
2012-01-04 2011-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise -37.767 75.533 -33,33
2012-01-04 2011-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 113.300 113.300
2012-01-04 2011-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes -16.410 62.218 -20,87 8,12 -133.249 505.210
2012-01-04 2011-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 37.767 78.628 92,43
2012-01-04 2011-07-13 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -2.890 40.861 -6,61
2012-01-04 2011-07-05 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -2.919 43.751 -6,25
P
Piața deschisă sau achiziția privată de titluri nederivate sau derivate
S
Piața deschisă sau vânzarea privată a titlurilor de valoare nederivate sau derivate
A
Acordarea, atribuirea sau alte achiziții de valori mobiliare de la companie (cum ar fi o opțiune)
C
Conversia derivatei
D
Vânzarea sau transferul de valori mobiliare înapoi către companie
F
Plata prețului de exercițiu sau a obligației fiscale folosind o parte din titlurile de valoare primite de la companie
G
Donarea de valori mobiliare de către sau către persoane din interior
K
Swap-uri de acțiuni și tranzacții similare de acoperire împotriva riscurilor
M
Exercitarea sau conversia titlurilor derivate primite de la companie (cum ar fi o opțiune)
V
O tranzacție raportată voluntar pe Formularul 4
J
Altele (însoțite de o notă de subsol care descrie tranzacția)